Overview
Prithviraj Bose is a Hematologist in Cary, North Carolina. Dr. Bose is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Myelofibrosis, Essential Thrombocythemia, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 228 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles and participated in 3 clinical trials in the study of Mast Cell Activation Syndrome (MCAS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
210 Ashville Ave # 408, Cary, NC 27518
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Duke Blood Cancer Center
I have the privilege of caring for patients with various myeloproliferative neoplasms including, polycythemia vera, essential thrombocytosis, primary myelofibrosis, systemic mastocytosis, and chronic myeloid leukemia. My goal is to provide the best possible care for each individual patient in an era where the number of therapeutic options for patients with myeloproliferative neoplasms is rapidly expanding. As a clinical investigator leading several clinical studies in both early and late stages of development, I strive to offer patients access to investigational agents with novel mechanisms of action via participation in clinical trials. I believe that every patient has a unique diagnosis and personal experience with their cancer. I aim to consider the disease, the patient and individual care goals in partnering with patients to develop and implement personalized treatment plans. Dr. Rein is rated as a Distinguished provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
UT MD Anderson Cancer Center
Beenu Thakral is a Hematologist in Cary, North Carolina. Dr. Thakral is rated as a Distinguished provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Chronic T-Cell Leukemia (CTCL), Prolymphocytic Leukemia, Leukemia, Bone Marrow Aspiration, and Splenectomy.
UT MD Anderson Cancer Center
Uday Popat is a Hematologist in Cary, North Carolina. Dr. Popat is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Essential Thrombocythemia
- LeukemiaDr. Bose isElite. Learn about Leukemia.
- Mast Cell Activation Syndrome (MCAS)
- Distinguished
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- AnemiaDr. Bose isDistinguished. Learn about Anemia.
- Castleman DiseaseDr. Bose isDistinguished. Learn about Castleman Disease.
- Childhood Acute Myeloid LeukemiaDr. Bose isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Bose isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Blood ClotsDr. Bose isAdvanced. Learn about Blood Clots.
- Bone Marrow AspirationDr. Bose isAdvanced. Learn about Bone Marrow Aspiration.
- Drug-Induced ThrombocytopeniaDr. Bose isAdvanced. Learn about Drug-Induced Thrombocytopenia.
- Febrile NeutropeniaDr. Bose isAdvanced. Learn about Febrile Neutropenia.
- LeukocytosisDr. Bose isAdvanced. Learn about Leukocytosis.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Bose isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Bose isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Bose isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Bose isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Bose isExperienced. Learn about Aplastic Anemia.
- Autoimmune Hemolytic AnemiaDr. Bose isExperienced. Learn about Autoimmune Hemolytic Anemia.
